Exchange: NASDAQ·Updated 07:30 PM EDT
CDXS logo

CDXS Codexis Inc.

$1.46
$0.04
(2.82%)
Today
Closed $1.46
$0.01
(0.69%)
After Hours
Reported EarningsAug 11
Mkt Cap$159.88M
Vol757,840.00

About CDXS

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.
43

Bearish Sentiment

How do you feel about CDXS?

Advertisement|Remove ads.